Starting today, fans can shop the Hot Wheels x Mercedes-Benz Project G-Class Past II Future replica designed by NIGO on ...

Prescription drugs for obesity are gaining attention as lifestyle changes alone often fall short. Teva Pharmaceuticals (Teva) has launched the first generic glucagon-like peptide-1 (GLP-1) drug for ...

Wednesday, September 24, 2025, at 9:00 A.M. British Summer Time (4.00 A.M. Eastern Time) To access a live webcast of the presentation, visit Teva’s Investor ...

Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy growth stocks to buy now. On August 28, Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced the FDA approval ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva's ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...

Teva's generic Saxenda is the first generic GLP-1 indicated for weight loss. Richardsen added, “This is the fifth first-to-market entry of a Teva generic this year and is an important addition to Teva ...

PARSIPPANY, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the FDA approval and U.S.